Published in Eur J Clin Pharmacol on January 01, 1993
Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine. Br J Clin Pharmacol (2001) 1.04
Role of cytochrome P450 in drug interactions. Nutr Metab (Lond) (2008) 0.97
Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. Br J Clin Pharmacol (2001) 0.96
Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity. Br J Clin Pharmacol (1999) 0.80
Risk factors for drug-induced long-QT syndrome. Neth Heart J (2005) 0.77
Possible drug-drug interaction in dogs and cats resulted from alteration in drug metabolism: A mini review. J Adv Res (2015) 0.75
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values. J Am Coll Cardiol (1994) 3.35
Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation (2001) 3.34
Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation (2007) 1.98
Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ (1998) 1.77
Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol (1999) 1.68
Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Eur Heart J (1999) 1.67
Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol (1999) 1.59
Repolarization abnormalities detected by magnetocardiography in patients with dilated cardiomyopathy and ventricular arrhythmias. J Cardiovasc Electrophysiol (2001) 1.45
A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics. J Am Coll Cardiol (2001) 1.39
Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med (2009) 1.35
Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction. J Hypertens (2001) 1.17
Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J (1996) 1.14
Rate adaptation of QT intervals during and after exercise in children with congenital long QT syndrome. Eur Heart J (1998) 1.13
Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. Heart (2006) 1.12
Torsades de pointes after terfenadine-itraconazole interaction. BMJ (1993) 1.10
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol (2001) 1.10
Reversal of autonomic derangements by physical training in chronic heart failure assessed by heart rate variability. Eur Heart J (1995) 1.06
QT interval as a cardiac risk factor in a middle aged population. Heart (1997) 1.06
Effects of acute alcohol infusion on duration and dispersion of QT interval in male patients with coronary artery disease and in healthy controls. Clin Cardiol (1999) 1.05
Effect of ethanol drinking, hangover, and exercise on adrenergic activity and heart rate variability in patients with a history of alcohol-induced atrial fibrillation. Am J Cardiol (1998) 1.04
Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects. Hum Mutat (2000) 1.02
Effects of toxic and non-toxic cyanobacteria on grazing, zooplanktivory and survival of the mysid shrimp Mysis mixta. J Exp Mar Bio Ecol (2001) 1.01
More light on QT interval measurement. Heart (2002) 1.00
Cellular Fatty Acid profiles of lactobacillus and lactococcus strains in relation to the oleic Acid content of the cultivation medium. Appl Environ Microbiol (1995) 0.99
Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns. J Am Coll Cardiol (2000) 0.98
Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome. J Intern Med (1997) 0.98
Evaluation of QT interval duration and dispersion and proposed clinical criteria in diagnosis of long QT syndrome in patients with a genetically uniform type of LQT1. J Am Coll Cardiol (1998) 0.96
The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation. Eur Heart J (1993) 0.96
Response of the QT interval to mental and physical stress in types LQT1 and LQT2 of the long QT syndrome. Heart (2001) 0.95
Magnetocardiographic QT interval dispersion in postmyocardial infarction patients with sustained ventricular tachycardia: validation of automated QT measurements. Pacing Clin Electrophysiol (1998) 0.95
Left ventricular function in children with the Marfan syndrome. Eur Heart J (1994) 0.95
Dispersions of the QT interval in postmyocardial infarction patients presenting with ventricular tachycardia or with ventricular fibrillation. Am J Cardiol (1998) 0.95
Effects of acute alcohol ingestion on heart rate variability in patients with documented coronary artery disease and stable angina pectoris. Am J Cardiol (1997) 0.94
Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol (1999) 0.94
Multiple forms of sustained monomorphic ventricular tachycardia as common presentation in giant-cell myocarditis. Heart (2007) 0.93
Fever and cardiac rhythm. Arch Intern Med (1986) 0.92
Aortic distensibility in children with the Marfan syndrome. Am J Cardiol (1992) 0.92
Extensive variation in the signal amplitude of the atrial floating VDD pacing electrode. Pacing Clin Electrophysiol (1998) 0.92
Identification of patients with ventricular tachycardia after myocardial infarction by high-resolution magnetocardiography and electrocardiography. J Electrocardiol (1993) 0.89
Electrocardiographic repolarization during stress from awakening on alarm call. J Am Coll Cardiol (1997) 0.88
Persistent ventricular tachycardia resulting in left ventricular dilatation treated with verapamil. Int J Cardiol (1986) 0.86
Exclusion of coronary artery disease by exercise thallium-201 tomography in patients with aortic valve stenosis. Am J Cardiol (1992) 0.86
Electrophysiologic effects of a calcium sensitizer inotrope levosimendan administered intravenously in patients with normal cardiac function. J Cardiovasc Pharmacol (2000) 0.85
Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience. Radiology (2000) 0.85
Molecular genetics of the long QT syndrome: two novel mutations of the KVLQT1 gene and phenotypic expression of the mutant gene in a large kindred. Hum Mutat (1998) 0.84
QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids. Am J Cardiol (1999) 0.83
QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart (1997) 0.83
Effects of hydrochlorothiazide, furosemide and ethacrynic acid on the tissue noradrenaline. Ann Med Exp Biol Fenn (1968) 0.83
Effect of light on the feeding rates of pelagic and littoral mysid shrimps: a trade-off between feeding success and predation avoidance. J Exp Mar Bio Ecol (2001) 0.83
Magnetocardiographic localization of ventricular pre-excitation in a child with a congenital heart defect. Pediatr Cardiol (1995) 0.81
Effect of the antimalarial drug halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A. Am J Cardiol (2001) 0.81
Effect of diuretics on lipolysis in the rat. Ann Med Exp Biol Fenn (1967) 0.81
Provocation of ventricular tachycardia by antimalarial drug halofantrine in congenital long QT syndrome. Clin Cardiol (1994) 0.81
Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol (1998) 0.81
Acute heavy alcohol intake increases silent myocardial ischaemia in patients with stable angina pectoris. Heart (1996) 0.81
Non-invasive magnetocardiographic localization of ventricular pre-excitation in the Wolff-Parkinson-White syndrome using a realistic torso model. Eur Heart J (1993) 0.80
24-Hour electrocardiographic recordings in mild acute infectious myocarditis. Ann Clin Res (1984) 0.80
The impact of fibrin glue in the prevention of failure after Nissen fundoplication. Scand J Surg (2011) 0.80
Alcohol and sauna bathing: effects on cardiac rhythm, blood pressure, and serum electrolyte and cortisol concentrations. J Intern Med (1992) 0.80
Arrhythmias and ST segment deviation during prolonged exhaustive exercise (ski marathon) in healthy middle-aged men. Eur Heart J (1994) 0.80
Localization of accessory pathways in Wolff-Parkinson-White syndrome by high-resolution magnetocardiographic mapping. J Electrocardiol (1992) 0.79
Left ventricular mass, geometry, and filling in endurance athletes: association with exercise blood pressure. J Appl Physiol (1985) (1997) 0.79
Heart rate adjustment of magnetic field map rotation in detection of myocardial ischemia in exercise magnetocardiography. Basic Res Cardiol (2002) 0.79
Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure. J Am Coll Cardiol (1999) 0.79
Later potentials on signal-averaged electrocardiograms in children after right ventriculotomy. Pediatr Cardiol (1995) 0.78
Comparison of current density viability imaging at rest with FDG-PET in patients after myocardial infarction. Comput Med Imaging Graph (2008) 0.78
Current-density estimation of exercise-induced ischemia in patients with multivessel coronary artery disease. J Electrocardiol (2001) 0.78
Imbalance of the autonomic nervous system at night in women with gestational diabetes. Diabet Med (2010) 0.78
Enalaprilat in acute intractable heart failure after myocardial infarction: a prospective, consecutive sample, before-after trial. Crit Care Med (1994) 0.78
Autonomic modulation of QT intervals in post-myocardial infarction patients with and without ventricular fibrillation. Am J Cardiol (1998) 0.78
Postmyocardial infarction patients susceptible to ventricular tachycardia show increased T wave dispersion independent of delayed ventricular conduction. J Cardiovasc Electrophysiol (2001) 0.78
Recording locations in multichannel magnetocardiography and body surface potential mapping sensitive for regional exercise-induced myocardial ischemia. Basic Res Cardiol (2001) 0.78
Comparison of cyclophilin binding assay and radioimmunoassay in monitoring of blood cyclosporine. Ther Drug Monit (1997) 0.78
Anaesthesia for microvascular surgery in children. A combination of general anaesthesia and axillary plexus block. Acta Anaesthesiol Scand (1995) 0.78
The performance of the probability density function in differentiating supraventricular from ventricular rhythms. Pacing Clin Electrophysiol (1992) 0.77
Magnetocardiographic intra-QRS fragmentation analysis in the identification of patients with sustained ventricular tachycardia after myocardial infarction. Pacing Clin Electrophysiol (2001) 0.77
Electrocardiographic assessment of left ventricular hypertrophy with time-voltage QRS and QRST-wave areas. J Hum Hypertens (2004) 0.77
Plasma and pericardial fluid natriuretic peptide levels in postinfarction ventricular dysfunction. Eur J Heart Fail (2001) 0.77
Changes in heart rate variability in elderly patients undergoing major noncardiac surgery under spinal or general anesthesia. Reg Anesth Pain Med (1999) 0.77